Schistosoma Japonicum Diagnostic Review and Epidemiological Data in China, 2015-2026

A 2026 review document aggregates findings from 37 studies on human seroprevalence and 24 studies on wild rodent prevalence of Schistosoma japonicum in China, covering literature from 2015 onward. The author, Fen Chen, compiled data from over 46 million human serum samples and 14,381 wild rodents. The work discusses diagnostic methods and epidemiological features to inform control strategies.

Use Cases

• Benchmarking seroprevalence rates based on aggregated data from 10 Chinese provinces.
• Comparing diagnostic method performance (e.g., Kato-Katz, PCR, LAMP, CRISPR/Cas) as discussed in the review.
• Analyzing risk factors for infection based on described demographic patterns like occupation and residency.
• Studying wildlife reservoir hosts using the reported infection rates in Rattus norvegicus and other rodent species.

Strengths

• Provides specific aggregated statistics, including a human seroprevalence rate of 1.54% from 46,910,186 samples and a rodent prevalence of 8.97% from 14,381 specimens.
• Covers a defined time period (2015-2026) and geographic scope (multiple Chinese provinces).
• Released under a permissive CC-BY-4.0 license for reuse.

Limitations

• The dataset is a review document (18.3 KB DOCX), not a primary data table; raw observational records are not directly accessible.
• Row and column structures are unknown, as the description summarizes findings rather than presenting a structured dataset.
• Freshness should be verified; the last update is 2026-05-28, which may be a future date indicating a placeholder.

Provenance

Source

Fen Chen, via figshare.

Collection Method

Narrative and descriptive synthesis of published literature.

Time Range

2015 to 2026

Freshness

Last updated 2026-05-28 04:48:08

Geography

China, specifically 10 provinces including Fujian and Yunnan.